Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Short term Debt (2016 - 2020)

Historic Short term Debt for Fortress Biotech (FBIO) over the last 6 years, with Q2 2020 value amounting to $413000.0.

  • Fortress Biotech's Short term Debt changed N/A to $413000.0 in Q2 2020 from the same period last year, while for Jun 2020 it was $413000.0, marking a year-over-year change of. This contributed to the annual value of $27000.0 for FY2019, which is 9727.55% down from last year.
  • Latest data reveals that Fortress Biotech reported Short term Debt of $413000.0 as of Q2 2020.
  • Fortress Biotech's 5-year Short term Debt high stood at $991000.0 for Q4 2018, and its period low was $16000.0 during Q1 2019.
  • Moreover, its 5-year median value for Short term Debt was $305500.0 (2016), whereas its average is $375125.0.
  • Per our database at Business Quant, Fortress Biotech's Short term Debt crashed by 9727.55% in 2019 and then skyrocketed by 33125.0% in 2020.
  • Over the past 5 years, Fortress Biotech's Short term Debt (Quarter) stood at $481000.0 in 2016, then crashed by 35.76% to $309000.0 in 2017, then soared by 220.71% to $991000.0 in 2018, then tumbled by 97.28% to $27000.0 in 2019, then skyrocketed by 1429.63% to $413000.0 in 2020.
  • Its Short term Debt stands at $413000.0 for Q2 2020, versus $69000.0 for Q1 2020 and $27000.0 for Q4 2019.